Pharmaceutical lobby
Pharmaceutical lobby
The Pharmaceutical lobby (pronunciation: /ˌfɑːrməˈsjuːtɪkəl ˈlɒbi/) refers to the collective group of representatives from the pharmaceutical industry who engage in lobbying activities to influence public policy and legislation in favor of their industry.
Etymology
The term "Pharmaceutical lobby" is derived from the words "pharmaceutical", which comes from the Greek word "pharmakeia" meaning "use of drugs, medicines, potions, or spells; poisoning, witchcraft", and "lobby", which has its origins in the mid-18th century (in the sense ‘monastic cloister’): from medieval Latin lobia, lobium ‘covered walk, portico’. The term "lobby" in the political context originated in the United States, where it was used to describe the lobbies or corridors of the Capitol in Washington, D.C., where people would go to influence legislators.
Related terms
- Pharmaceutical industry: The commercial industry responsible for the research, development, production, and distribution of drugs.
- Lobbying: The act of attempting to influence decisions made by officials in a government, most often legislators or members of regulatory agencies.
- Public policy: Governmental regulations, laws, and funding priorities concerning a given topic.
- Legislation: Laws, considered collectively, as enacted or proposed by a political body or an individual who is a member of that body.
See also
External links
- Medical encyclopedia article on Pharmaceutical lobby
- Wikipedia's article - Pharmaceutical lobby
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski